Methods for the screening and diagnosis of gestational diabetes mellitus between 24 and 28 weeks of pregnancy

被引:25
作者
Virally, M. [1 ]
Laloi-Michelin, M. [1 ]
机构
[1] Hop Lariboisiere, APHP, Serv Med B, F-75010 Paris, France
关键词
gestational diabetes mellitus; screening; oral glucose tolerance test; fasting glucose; glycated haemoglobin; review; GLUCOSE-TOLERANCE TEST; FASTING PLASMA-GLUCOSE; INTERNATIONAL WORKSHOP-CONFERENCE; HIGH-RISK POPULATION; BLOOD-GLUCOSE; SERUM FRUCTOSAMINE; CARBOHYDRATE DIET; GLYCOSURIA; TESTS; RECOMMENDATIONS;
D O I
10.1016/j.diabet.2010.11.008
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The aim of this review is to provide answers to the question "How does one screen for and diagnose gestational diabetes mellitus (GDM) between 24 and 28 weeks gestation?" Two methods are currently widely used: a one-step approach (the 75g-Oral Glucose Tolerance Test, OGTT) and a two-step approach (the 50g Glucose Challenge Test, GCT, followed by 100g-OGTT). A review of the literature showed that both methods had good reproducibility (around 80%), whilst neither required preliminary diet changes. The data of the Hyperglycaemia Adverse Pregnancy Outcomes (HAPO) study on materno-foetal morbidity provided consistent support in favour of the 75g-OGTT. In addition, this one-step method presents several advantages over the two-step method, i.e. it provides a faster diagnosis time, better tolerance and it is easier to remember. We thus recommend a 75g-OGTT including three measures of the glycaemia at times 0, 1 and 2 hours for the diagnosis of GDM between 24-28 weeks of pregnancy. A discussion of alternative methods revealed that measuring Fasting Glycaemia (FG) between 24 and 28 weeks of pregnancy was unsuitable, and that measuring HbA(1c), fructosamine, glycosuria, or random and postprandial plasma glucose was not advisable. This is based on the fact that too few studies have evaluated these methods, and that the studies usually involved heterogeneous populations in varying numbers, using differing criteria and sensitivity values. However, HbA(1c) measurements may prove useful in detecting pre-pregnancy diabetes mellitus. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:549 / 565
页数:17
相关论文
共 89 条
[1]
Gestational diabetes: An alternative, patient-friendly approach for using the diagnostic 100-g OGTT in high-risk populations [J].
Agarwal M.M. ;
Dhatt G.S. ;
Punnose J. .
Archives of Gynecology and Obstetrics, 2006, 273 (6) :325-330
[2]
Gestational diabetes: utility of fasting plasma glucose as a screening test depends on the diagnostic criteria [J].
Agarwal, M. M. ;
Dhatt, G. S. ;
Punnose, J. .
DIABETIC MEDICINE, 2006, 23 (12) :1319-1326
[3]
Gestational diabetes: a reappraisal of HBA1c as a screening test [J].
Agarwal, MM ;
Dhatt, GS ;
Punnose, J ;
Koster, G .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2005, 84 (12) :1159-1163
[4]
Gestational diabetes screening of a multiethnic, high-risk population using glycated proteins [J].
Agarwal, MM ;
Hughes, PF ;
Punnose, J ;
Ezimokhai, M ;
Thomas, L .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 51 (01) :67-73
[5]
Gestational diabetes in a high-risk population: using the fasting plasma glucose to simplify the diagnostic algorithm [J].
Agarwal, MM ;
Dhatt, GS ;
Punnose, J ;
Koster, G .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 120 (01) :39-44
[6]
Gestational diabetes: problems associated with the oral glucose tolerance test [J].
Agarwal, MM ;
Punnose, J ;
Dhatt, GS .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 63 (01) :73-74
[7]
Fasting plasma glucose as a screening test for gestational diabetes mellitus [J].
Agarwal M.M. ;
Dhatt G.S. .
Archives of Gynecology and Obstetrics, 2007, 275 (2) :81-87
[8]
Agarwal MM, 2007, J REPROD MED, V52, P299
[9]
Alto WA, 2005, J FAM PRACTICE, V54, P978